PropertyValue
?:abstract
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been used experimentally in patients with acute respiratory distress syndrome. Recombinant GM-CSF administered by direct inhalation is currently being studied in a cohort of patients with advanced COVID-19.
?:creator
?:doi
  • 10.3949/ccjm.87a.ccc057
?:doi
?:journal
  • Cleveland_Clinic_journal_of_medicine
?:license
  • unk
?:pmid
?:pmid
  • 32753517.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF.
?:type
?:year
  • 2020-08-04

Metadata

Anon_0  
expand all